REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640101. A total of 35 filers reported holding REXAHN PHARMACEUTICALS INC in Q1 2015. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $65,000 | +282.4% | 127,389 | +7.2% | 0.00% | – |
| Q4 2016 | $17,000 | -34.6% | 118,879 | -5.7% | 0.00% | – |
| Q3 2016 | $26,000 | -29.7% | 126,014 | -13.3% | 0.00% | – |
| Q2 2016 | $37,000 | -22.9% | 145,304 | 0.0% | 0.00% | – |
| Q1 2016 | $48,000 | -9.4% | 145,304 | 0.0% | 0.00% | – |
| Q4 2015 | $53,000 | -30.3% | 145,304 | 0.0% | 0.00% | – |
| Q3 2015 | $76,000 | -13.6% | 145,304 | 0.0% | 0.00% | – |
| Q2 2015 | $88,000 | -5.4% | 145,304 | +13.5% | 0.00% | – |
| Q1 2015 | $93,000 | +3.3% | 128,027 | 0.0% | 0.00% | – |
| Q4 2014 | $90,000 | -13.5% | 128,027 | 0.0% | 0.00% | – |
| Q3 2014 | $104,000 | -53.2% | 128,027 | -50.0% | 0.00% | – |
| Q2 2014 | $222,000 | +393.3% | 256,054 | +518.5% | 0.00% | – |
| Q1 2014 | $45,000 | -33.8% | 41,401 | -73.0% | 0.00% | – |
| Q2 2013 | $68,000 | – | 153,187 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUDSON VALLEY INVESTMENT ADVISORS INC /ADV | 20,000 | $57,000 | 0.02% |